GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet395: 709–733, 2020PubMed
GBD Chronic Kidney Disease Collaboration: Global, regional, and national burden of chronic kidney disease, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 395: 709–733, 2020PubMed)| false
MillsKT, XuY, ZhangW, BundyJD, ChenCS, KellyTN, et al.A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int88: 950–957, 2015PubMed
MillsKT, XuY, ZhangW, BundyJD, ChenCS, KellyTN, et al.A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88: 950–957, 2015PubMed)| false
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Lond Engl.388: 1775–1812, 2016
GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Lond Engl. 388: 1775–1812, 2016)| false
CarreroJJ, de JagerDJ, VerduijnM, RavaniP, De MeesterJ, HeafJG, et al.Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol6: 1722–1730, 2011PubMed
CarreroJJ, de JagerDJ, VerduijnM, RavaniP, De MeesterJ, HeafJG, et al.Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol 6: 1722–1730, 2011PubMed)| false
OrtonaE, PierdominiciM, MaselliA, VeroniC, AloisiF, ShoenfeldY: Sex-based differences in autoimmune diseases. Ann Ist Super Sanita52: 205–212, 2016PubMed
OrtonaE, PierdominiciM, MaselliA, VeroniC, AloisiF, ShoenfeldY: Sex-based differences in autoimmune diseases. Ann Ist Super Sanita 52: 205–212, 2016PubMed)| false
SpaldingEM, ChandnaSM, DavenportA, FarringtonK: Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int 74: 348–355, 2008PubMed)| false
EknoyanG, BeckGJ, CheungAK, DaugirdasJT, GreeneT, KusekJW, et al; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med347: 2010–2019, 2002PubMed
EknoyanG, BeckGJ, CheungAK, DaugirdasJT, GreeneT, KusekJW, et al; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010–2019, 2002PubMed)| false
PiccoliGB, ZakharovaE, AttiniR, Ibarra HernandezM, Orozco GuillienA, AlrukhaimiM, et al.Pregnancy in chronic kidney disease: Need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases. J Clin Med7: 415, 2018PubMed
PiccoliGB, ZakharovaE, AttiniR, Ibarra HernandezM, Orozco GuillienA, AlrukhaimiM, et al.Pregnancy in chronic kidney disease: Need for higher awareness. A pragmatic review focused on what could be improved in the different CKD stages and phases. J Clin Med 7: 415, 2018PubMed)| false
VrijlandtWAL, de JongMFC, PrinsJR, BramhamK, VrijlandtPJWS, JanseRJ, et al.Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J Nephrol36: 1341–1347, 2023PubMed
VrijlandtWAL, de JongMFC, PrinsJR, BramhamK, VrijlandtPJWS, JanseRJ, et al.Prevalence of chronic kidney disease in women of reproductive age and observed birth rates. J Nephrol 36: 1341–1347, 2023PubMed)| false
MauleSP, AshworthDC, BlakeyH, OsafoC, MoturiM, ChappellLC, et al.CKD and pregnancy outcomes in Africa: A narrative review. Kidney Int Rep5: 1342–1349, 2020PubMed
MauleSP, AshworthDC, BlakeyH, OsafoC, MoturiM, ChappellLC, et al.CKD and pregnancy outcomes in Africa: A narrative review. Kidney Int Rep 5: 1342–1349, 2020PubMed)| false
TangrenJ, BathiniL, JeyakumarN, DixonSN, RayJ, WaldR, et al.Pre-pregnancy eGFR and the risk of adverse maternal and fetal outcomes: A population-based study. J Am Soc Nephrol34: 656–667, 2023PubMed
TangrenJ, BathiniL, JeyakumarN, DixonSN, RayJ, WaldR, et al.Pre-pregnancy eGFR and the risk of adverse maternal and fetal outcomes: A population-based study. J Am Soc Nephrol 34: 656–667, 2023PubMed)| false
PiccoliGB, CabidduG, AttiniR, VigottiFN, MaxiaS, LeporiN, et al.Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol26: 2011–2022, 2015PubMed
PiccoliGB, CabidduG, AttiniR, VigottiFN, MaxiaS, LeporiN, et al.Risk of adverse pregnancy outcomes in women with CKD. J Am Soc Nephrol 26: 2011–2022, 2015PubMed)| false
PiccoliGB, ChatrenetA, CataldoM, TorreggianiM, AttiniR, MasturzoB, et al.Adding creatinine to routine pregnancy tests: A decision tree for calculating the cost of identifying patients with CKD in pregnancy. Nephrol Dial Transplant 38: 148–157, 2023.
PiccoliGB, ChatrenetA, CataldoM, TorreggianiM, AttiniR, MasturzoB, et al.Adding creatinine to routine pregnancy tests: A decision tree for calculating the cost of identifying patients with CKD in pregnancy. Nephrol Dial Transplant 38: 148–157, 2023.)| false
BramhamK, SeedPT, LightstoneL, Nelson-PiercyC, GillC, WebsterP, et al.Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int89: 874–885, 2016PubMed
BramhamK, SeedPT, LightstoneL, Nelson-PiercyC, GillC, WebsterP, et al.Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease. Kidney Int 89: 874–885, 2016PubMed)| false
WilesK, ChappellL, ClarkK, ElmanL, HallM, LightstoneL, et al.Clinical practice guideline on pregnancy and renal disease. BMC Nephrol20: 401, 2019PubMed
Mc LaughlinL, JonesC, NeukirchingerB, NoyesJ, StoneJ, WilliamsH, et al.Feminizing care pathways: Mixed-methods study of reproductive options, decision making, pregnancy, post-natal care and parenting amongst women with kidney disease. J Adv Nurs79: 3127–3146, 2023PubMed
Mc LaughlinL, JonesC, NeukirchingerB, NoyesJ, StoneJ, WilliamsH, et al.Feminizing care pathways: Mixed-methods study of reproductive options, decision making, pregnancy, post-natal care and parenting amongst women with kidney disease. J Adv Nurs 79: 3127–3146, 2023PubMed)| false
TongA, BrownMA, WinkelmayerWC, CraigJC, JesudasonS: Perspectives on pregnancy in women with CKD: A semistructured interview study. Am J Kidney Dis66: 951–961, 2015PubMed
TongA, BrownMA, WinkelmayerWC, CraigJC, JesudasonS: Perspectives on pregnancy in women with CKD: A semistructured interview study. Am J Kidney Dis 66: 951–961, 2015PubMed)| false
Álvarez-VillarrealM, Velarde-GarcíaJF, García-BravoC, Carrasco-GarridoP, Jimenez-AntonaC, Moro-Lopez-MencheroP, et al.The experience of being a mother with end stage renal disease: A qualitative study of women receiving treatment at an ambulatory dialysis unit. PLoS One16: e0257691, 2021PubMed
Álvarez-VillarrealM, Velarde-GarcíaJF, García-BravoC, Carrasco-GarridoP, Jimenez-AntonaC, Moro-Lopez-MencheroP, et al.The experience of being a mother with end stage renal disease: A qualitative study of women receiving treatment at an ambulatory dialysis unit. PLoS One 16: e0257691, 2021PubMed)| false
HendrenEM, ReynoldsML, MarianiLH, ZeeJ, O’ShaughnessyMM, OliverioAL, et al.Confidence in women’s health: A cross border survey of adult nephrologists. J Clin Med 8: 176, 2019PubMed)| false
ChangDH, DumanskiSM, AhmedSB: Female reproductive and gynecologic considerations in chronic kidney disease: Adolescence and young adulthood. Kidney Int Rep7: 152–164, 2021PubMed
ChangDH, DumanskiSM, AhmedSB: Female reproductive and gynecologic considerations in chronic kidney disease: Adolescence and young adulthood. Kidney Int Rep 7: 152–164, 2021PubMed)| false
QuanA: Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev82: 23–28, 2006PubMed
QuanA: Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Early Hum Dev 82: 23–28, 2006PubMed)| false
LiDK, YangC, AndradeS, TavaresV, FerberJR: Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: A retrospective cohort study. BMJ343: d5931, 2011PubMed
LiDK, YangC, AndradeS, TavaresV, FerberJR: Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: A retrospective cohort study. BMJ 343: d5931, 2011PubMed)| false
WilesK, ChappellLC, LightstoneL, BramhamK: Updates in diagnosis and management of preeclampsia in women with CKD. Clin J Am Soc Nephrol15: 1371–1380, 2020PubMed
WilesK, ChappellLC, LightstoneL, BramhamK: Updates in diagnosis and management of preeclampsia in women with CKD. Clin J Am Soc Nephrol 15: 1371–1380, 2020PubMed)| false
RolnikDL, WrightD, PoonLC, O’GormanN, SyngelakiA, de Paco MatallanaC, et al.Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med377: 613–622, 2017PubMed
RolnikDL, WrightD, PoonLC, O’GormanN, SyngelakiA, de Paco MatallanaC, et al.Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 377: 613–622, 2017PubMed)| false
HendersonJT, WhitlockEP, O’ConnorE, SengerCA, ThompsonJH, RowlandMG: Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med160: 695–703, 2014PubMed
HendersonJT, WhitlockEP, O’ConnorE, SengerCA, ThompsonJH, RowlandMG: Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 160: 695–703, 2014PubMed)| false
WilesK, BramhamK, SeedPT, BrockbankA, Nelson-PiercyC, KarumanchiSA, et al.Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens24: 58–64, 2021PubMed
WilesK, BramhamK, SeedPT, BrockbankA, Nelson-PiercyC, KarumanchiSA, et al.Placental and endothelial biomarkers for the prediction of superimposed pre-eclampsia in chronic kidney disease. Pregnancy Hypertens 24: 58–64, 2021PubMed)| false
Morales-MartínezFA, Salas-CastroC, García-GarzaMR, Valdés-MartínezO, García-LunaSM, Garza-ElizondoM, et al.Evaluation of the ovarian reserve in women with systemic lupus erythematosus. J Family Reprod Health15: 38–44, 2021PubMed
Morales-MartínezFA, Salas-CastroC, García-GarzaMR, Valdés-MartínezO, García-LunaSM, Garza-ElizondoM, et al.Evaluation of the ovarian reserve in women with systemic lupus erythematosus. J Family Reprod Health 15: 38–44, 2021PubMed)| false
Di MarioC, PetriccaL, GiganteMR, BariniA, BariniA, VarrianoV, et al.Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve. Endocrine63: 369–375, 2019PubMed
Di MarioC, PetriccaL, GiganteMR, BariniA, BariniA, VarrianoV, et al.Anti-Müllerian hormone serum levels in systemic lupus erythematosus patients: Influence of the disease severity and therapy on the ovarian reserve. Endocrine 63: 369–375, 2019PubMed)| false
MorelN, BachelotA, ChakhtouraZ, Ghillani-DalbinP, AmouraZ, GalicierL, et al; PLUS group: Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. J Clin Endocrinol Metab98: 3785–3792, 2013PubMed
MorelN, BachelotA, ChakhtouraZ, Ghillani-DalbinP, AmouraZ, GalicierL, et al; PLUS group: Study of anti-Müllerian hormone and its relation to the subsequent probability of pregnancy in 112 patients with systemic lupus erythematosus, exposed or not to cyclophosphamide. J Clin Endocrinol Metab 98: 3785–3792, 2013PubMed)| false
OishiY, IkeuchiH, HamataniH, NakasatomiM, SakairiT, KanekoY, et al.Pregnancy outcomes in patients with systemic lupus erythematosus with or without a history of lupus nephritis. Clin Exp Nephrol25: 835–843, 2021PubMed
OishiY, IkeuchiH, HamataniH, NakasatomiM, SakairiT, KanekoY, et al.Pregnancy outcomes in patients with systemic lupus erythematosus with or without a history of lupus nephritis. Clin Exp Nephrol 25: 835–843, 2021PubMed)| false
BramhamK, HuntBJ, BewleyS, GermainS, CalatayudI, KhamashtaMA, et al.Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol38: 1906–1913, 2011PubMed
BramhamK, HuntBJ, BewleyS, GermainS, CalatayudI, KhamashtaMA, et al.Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol 38: 1906–1913, 2011PubMed)| false
SammaritanoLR, BermasBL, ChakravartyEE, ChambersC, ClowseMEB, LockshinMD, et al.2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol72: 529–556, 2020PubMed
SammaritanoLR, BermasBL, ChakravartyEE, ChambersC, ClowseMEB, LockshinMD, et al.2020 American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol 72: 529–556, 2020PubMed)| false
AndreoliL, BertsiasGK, Agmon-LevinN, BrownS, CerveraR, Costedoat-ChalumeauN, et al.EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis76: 476–485, 2017PubMed
AndreoliL, BertsiasGK, Agmon-LevinN, BrownS, CerveraR, Costedoat-ChalumeauN, et al.EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76: 476–485, 2017PubMed)| false
SilverR, CraigoS, PorterF, OsmundsonSS, KullerJA, NortonME; Society for Maternal-Fetal Medicine (SMFM). Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol228: B41–B60, 2023PubMed
SilverR, CraigoS, PorterF, OsmundsonSS, KullerJA, NortonME; Society for Maternal-Fetal Medicine (SMFM). Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 228: B41–B60, 2023PubMed)| false
AnderssonNW, SkovL, AndersenJT: Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: A nationwide cohort study. Rheumatology (Oxford)60: 2317–2326, 2021PubMed
AnderssonNW, SkovL, AndersenJT: Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: A nationwide cohort study. Rheumatology (Oxford) 60: 2317–2326, 2021PubMed)| false
DuanJ, MaD, WenX, GuoQ, GaoJ, ZhangG, et al.Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis. Lupus30: 1163–1174, 2021PubMed
DuanJ, MaD, WenX, GuoQ, GaoJ, ZhangG, et al.Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis. Lupus 30: 1163–1174, 2021PubMed)| false
FanouriakisA, KostopoulouM, AndersenJ, AringerM, ArnaudL, BaeSC, et al.EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum DisOct 12: ard-2023–224762, 2023
FanouriakisA, KostopoulouM, AndersenJ, AringerM, ArnaudL, BaeSC, et al.EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis Oct 12: ard-2023–224762, 2023)| false
PetriM, LandyH, ClowseMEB, GemzoeK, KhamashtaM, KurtineczM, et al.Belimumab use during pregnancy: A summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports. Ann Rheum Dis82: 217–225, 2023PubMed
PetriM, LandyH, ClowseMEB, GemzoeK, KhamashtaM, KurtineczM, et al.Belimumab use during pregnancy: A summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports. Ann Rheum Dis 82: 217–225, 2023PubMed)| false
Miranda-HernándezD, SánchezA, Sánchez-BrionesRE, Rivas-RuizR, Cruz-ReynosoL, Cruz-DomínguezP, et al.Impact of systemic lupus erythematosus on pregnancy: Analysis of a large 10-year longitudinal mexican cohort. J Clin Rheumatol27[6S]: S217–S223, 2021PubMed
Miranda-HernándezD, SánchezA, Sánchez-BrionesRE, Rivas-RuizR, Cruz-ReynosoL, Cruz-DomínguezP, et al.Impact of systemic lupus erythematosus on pregnancy: Analysis of a large 10-year longitudinal mexican cohort. J Clin Rheumatol 27[6S]: S217–S223, 2021PubMed)| false
IzmirlyPM, KimMY, LlanosC, LePU, GuerraMM, AskanaseAD, et al.Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis69: 1827–1830, 2010PubMed
IzmirlyPM, KimMY, LlanosC, LePU, GuerraMM, AskanaseAD, et al.Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 69: 1827–1830, 2010PubMed)| false
BarsalouJ, JaeggiE, LaskinCA, BrownP, TianSY, HamiltonRM, et al.Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: A single-centre cohort study. Rheumatology (Oxford)56: 1552–1559, 2017PubMed
BarsalouJ, JaeggiE, LaskinCA, BrownP, TianSY, HamiltonRM, et al.Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: A single-centre cohort study. Rheumatology (Oxford) 56: 1552–1559, 2017PubMed)| false
DingX, LiangM, WangH, SongQ, GuoX, SuW, et al.Prenatal stressful life events increase the prevalence of postpartum depression: Evidence from prospective cohort studies. J Psychiatr Res 160: 263–271, 2023PubMed)| false
NICE, 2021. Available at: https://www.nice.org.uk/guidance/ng201/chapter/Recommendations#routine-antenatal-clinical-care Accessed October 13, 2023)| false
McGroganA, FranssenCFM, de VriesCS. The incidence of primary glomerulonephritis worldwide: A systematic review of the literature. Nephrol Dial Transplant26: 414–430, 2011.
McGroganA, FranssenCFM, de VriesCS. The incidence of primary glomerulonephritis worldwide: A systematic review of the literature. Nephrol Dial Transplant 26: 414–430, 2011.)| false
WangF, LuJD, ZhuY, WangTT, XueJ: Renal outcomes of pregnant patients with immunoglobulin a nephropathy: A systematic review and meta-analysis. Am J Nephrol49: 214–224, 2019PubMed
WangF, LuJD, ZhuY, WangTT, XueJ: Renal outcomes of pregnant patients with immunoglobulin a nephropathy: A systematic review and meta-analysis. Am J Nephrol 49: 214–224, 2019PubMed)| false
PiccoliGB, KooijIA, AttiniR, MontersinoB, FassioF, GerbinoM, et al.A systematic review on materno-foetal outcomes in pregnant women with IgA nephropathy: A case of “late-maternal” preeclampsia?J Clin Med7: 212, 2018PubMed
PiccoliGB, KooijIA, AttiniR, MontersinoB, FassioF, GerbinoM, et al.A systematic review on materno-foetal outcomes in pregnant women with IgA nephropathy: A case of “late-maternal” preeclampsia? J Clin Med 7: 212, 2018PubMed)| false
JarrickS, LundbergS, StephanssonO, SymrengA, BottaiM, HöijerJ, et al.Pregnancy outcomes in women with immunoglobulin A nephropathy: A nationwide population-based cohort study. J Nephrol34: 1591–1598, 2021PubMed
JarrickS, LundbergS, StephanssonO, SymrengA, BottaiM, HöijerJ, et al.Pregnancy outcomes in women with immunoglobulin A nephropathy: A nationwide population-based cohort study. J Nephrol 34: 1591–1598, 2021PubMed)| false
KomatsudaA, WakuiH, YasudaT, ImaiH, MiuraAB, TsudaA, et al.Successful delivery in a pregnant women with crescentic IgA nephropathy. Intern Med33: 723–726, 1994PubMed
KomatsudaA, WakuiH, YasudaT, ImaiH, MiuraAB, TsudaA, et al.Successful delivery in a pregnant women with crescentic IgA nephropathy. Intern Med 33: 723–726, 1994PubMed)| false
SiligatoR, GembilloG, CernaroV, TorreF, SalvoA, GraneseR, et al.Maternal and fetal outcomes of pregnancy in nephrotic syndrome due to primary glomerulonephritis. Front Med (Lausanne)7: 563094, 2020PubMed
SiligatoR, GembilloG, CernaroV, TorreF, SalvoA, GraneseR, et al.Maternal and fetal outcomes of pregnancy in nephrotic syndrome due to primary glomerulonephritis. Front Med (Lausanne) 7: 563094, 2020PubMed)| false
Orozco GuillénOA, Velazquez SilvaRI, GonzalezBM, Becerra GambaT, Gutiérrez MarínA, ParedesNR, et al.Collapsing lesions and focal segmental glomerulosclerosis in pregnancy: A report of 3 cases. Am J Kidney Dis74: 837–843, 2019PubMed
RovinBH, AdlerSG, BarrattJ, BridouxF, BurdgeKA, ChanTM, et al; Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int100[4S]: S1–S276, 2021PubMed
RovinBH, AdlerSG, BarrattJ, BridouxF, BurdgeKA, ChanTM, et al; Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group: KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 100[4S]: S1–S276, 2021PubMed)| false
YangC, BakerPN, GrangerJP, DavidgeST, TongC: Long-term impacts of preeclampsia on the cardiovascular system of mother and offspring. Hypertension80: 1821–1833, 2023PubMed
YangC, BakerPN, GrangerJP, DavidgeST, TongC: Long-term impacts of preeclampsia on the cardiovascular system of mother and offspring. Hypertension 80: 1821–1833, 2023PubMed)| false
BarrettP, McCarthyF, EvansM, KublickasM, PerryI, StenvinkelP, et al.Preeclampsia and the risk of chronic kidney disease: A national registry-based cohort study. Eur J Public Health30: ckaa165.1174, 2020
BarrettP, McCarthyF, EvansM, KublickasM, PerryI, StenvinkelP, et al.Preeclampsia and the risk of chronic kidney disease: A national registry-based cohort study. Eur J Public Health 30: ckaa165.1174, 2020)| false
ReynoldsML, OliverioAL, ZeeJ, HendrenEM, O’ShaughnessyMM, AyoubI, et al.Pregnancy history and kidney disease progression among women enrolled in cure glomerulonephropathy. Kidney Int Rep8: 805–817, 2023PubMed
ReynoldsML, OliverioAL, ZeeJ, HendrenEM, O’ShaughnessyMM, AyoubI, et al.Pregnancy history and kidney disease progression among women enrolled in cure glomerulonephropathy. Kidney Int Rep 8: 805–817, 2023PubMed)| false
NogueiraE, AfonsoR, GodinhoI, CentenoM, PintoL, LopesJA. Glomerulopathies during pregnancy: A ten-year single center experience. Nephrol Dial Transplant38: gfad063c_351, 2023.
SvetitskyS, LightstoneL, WilesK. Pregnancy in women with nephrotic-range proteinuria: A retrospective cohort study. Obstet Med Published online October 9, 2023https://journals.sagepub.com/doi/10.1177/1753495X231201896)| false
ReidyKJ, HjortenR, ParekhRS: Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry. Curr Opin Pediatr30: 252–259, 2018PubMed
ReidyKJ, HjortenR, ParekhRS: Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry. Curr Opin Pediatr 30: 252–259, 2018PubMed)| false
ReidyKJ, HjortenRC, SimpsonCL, RosenbergAZ, RosenblumSD, KovesdyCP, et al.Fetal-not maternal-APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am J Hum Genet103: 367–376, 2018PubMed
ReidyKJ, HjortenRC, SimpsonCL, RosenbergAZ, RosenblumSD, KovesdyCP, et al.Fetal-not maternal-APOL1 genotype associated with risk for preeclampsia in those with African ancestry. Am J Hum Genet 103: 367–376, 2018PubMed)| false
LanktreeMB, HaghighiA, GuiardE, IliutaIA, SongX, HarrisPC, et al.Prevalence estimates of polycystic kidney and liver disease by population sequencing. J Am Soc Nephrol29: 2593–2600, 2018PubMed
LanktreeMB, HaghighiA, GuiardE, IliutaIA, SongX, HarrisPC, et al.Prevalence estimates of polycystic kidney and liver disease by population sequencing. J Am Soc Nephrol 29: 2593–2600, 2018PubMed)| false
MüllerRU, MesschendorpAL, BirnH, CapassoG, Cornec-Le GallE, DevuystO, et al.An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: Consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrol Dial Transplant37: 825–839, 2022PubMed
MüllerRU, MesschendorpAL, BirnH, CapassoG, Cornec-Le GallE, DevuystO, et al.An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: Consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrol Dial Transplant 37: 825–839, 2022PubMed)| false
AapkesSE, BerntsLHP, BartenTRM, van den BergM, GansevoortRT, DrenthJPH: Estrogens in polycystic liver disease: A target for future therapies?Liver Int41: 2009–2019, 2021PubMed
AapkesSE, BerntsLHP, BartenTRM, van den BergM, GansevoortRT, DrenthJPH: Estrogens in polycystic liver disease: A target for future therapies? Liver Int 41: 2009–2019, 2021PubMed)| false
DaneshgarN, LiangPI, LanRS, HorstmannMM, PackL, BhardwajG, et al.Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations. Kidney Int101: 906–911, 2022PubMed
DaneshgarN, LiangPI, LanRS, HorstmannMM, PackL, BhardwajG, et al.Elamipretide treatment during pregnancy ameliorates the progression of polycystic kidney disease in maternal and neonatal mice with PKD1 mutations. Kidney Int 101: 906–911, 2022PubMed)| false
Matuszkiewicz-RowinskaJ, SkórzewskaK, RadowickiS, NiemczykS, SokalskiA, PrzedlackiJ, et al.Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis—a multicentre study. Nephrol Dial Transplant19: 2074–2077, 2004.
Matuszkiewicz-RowinskaJ, SkórzewskaK, RadowickiS, NiemczykS, SokalskiA, PrzedlackiJ, et al.Endometrial morphology and pituitary-gonadal axis dysfunction in women of reproductive age undergoing chronic haemodialysis—a multicentre study. Nephrol Dial Transplant 19: 2074–2077, 2004.)| false
HolleyJL, SchmidtRJ, BenderFH, DumlerF, SchiffM: Gynecologic and reproductive issues in women on dialysis. Am J Kidney Dis 29: 685–690, 1997PubMed)| false
HewawasamE, DaviesCE, GulyaniA, LiZ, ClaytonPA, SullivanE, et al.Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years. Nephrol Dial Transplant37: 1152–1161, 2022.
HewawasamE, DaviesCE, GulyaniA, LiZ, ClaytonPA, SullivanE, et al.Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years. Nephrol Dial Transplant 37: 1152–1161, 2022.)| false
BaoucheH, JaisJP, MeriemS, KarecheM, MoranneO, VigneauC, et al.Pregnancy in women on chronic dialysis in the last decade (2010–2020): A systematic review. Clin Kidney J16: 138–150, 2022PubMed
BaoucheH, JaisJP, MeriemS, KarecheM, MoranneO, VigneauC, et al.Pregnancy in women on chronic dialysis in the last decade (2010–2020): A systematic review. Clin Kidney J 16: 138–150, 2022PubMed)| false
HladunewichMA, HouS, OdutayoA, CornelisT, PierratosA, GoldsteinM, et al.Intensive hemodialysis associates with improved pregnancy outcomes: A Canadian and United States cohort comparison. J Am Soc Nephrol25: 1103–1109, 2014PubMed
HladunewichMA, HouS, OdutayoA, CornelisT, PierratosA, GoldsteinM, et al.Intensive hemodialysis associates with improved pregnancy outcomes: A Canadian and United States cohort comparison. J Am Soc Nephrol 25: 1103–1109, 2014PubMed)| false
JesudasonS, GraceBS, McDonaldSP: Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol9: 143–149, 2014PubMed
JesudasonS, GraceBS, McDonaldSP: Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol 9: 143–149, 2014PubMed)| false
CabidduG, CastellinoS, GernoneG, SantoroD, MoroniG, GiannattasioM, et al.A best practice position statement on pregnancy in chronic kidney disease: The Italian Study Group on Kidney and Pregnancy. J Nephrol29: 277–303, 2016PubMed
CabidduG, CastellinoS, GernoneG, SantoroD, MoroniG, GiannattasioM, et al.A best practice position statement on pregnancy in chronic kidney disease: The Italian Study Group on Kidney and Pregnancy. J Nephrol 29: 277–303, 2016PubMed)| false
JesudasonS, HewawasamE, MoloneyB, TanR, LiJ, BlakeyH, et al.Comparison of catheters or new arteriovenous fistulas for commencement of haemodialysis in pregnant women with chronic kidney disease: An international observational study. J Nephrol35: 1689–1698, 2022PubMed
JesudasonS, HewawasamE, MoloneyB, TanR, LiJ, BlakeyH, et al.Comparison of catheters or new arteriovenous fistulas for commencement of haemodialysis in pregnant women with chronic kidney disease: An international observational study. J Nephrol 35: 1689–1698, 2022PubMed)| false
HosfieldEM, RabbanJT, ChenLM, ZaloudekCJ: Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: Distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int J Gynecol Pathol27: 465–474, 2008PubMed
HosfieldEM, RabbanJT, ChenLM, ZaloudekCJ: Squamous metaplasia of the ovarian surface epithelium and subsurface fibrosis: Distinctive pathologic findings in the ovaries and fallopian tubes of patients on peritoneal dialysis. Int J Gynecol Pathol 27: 465–474, 2008PubMed)| false
ShahS, ChristiansonAL, MeganathanK, LeonardAC, SchauerDP, ThakarCV: Racial differences and factors associated with pregnancy in ESKD patients on dialysis in the United States. J Am Soc Nephrol30: 2437–2448, 2019PubMed
ShahS, ChristiansonAL, MeganathanK, LeonardAC, SchauerDP, ThakarCV: Racial differences and factors associated with pregnancy in ESKD patients on dialysis in the United States. J Am Soc Nephrol 30: 2437–2448, 2019PubMed)| false
BakerRJ, MarkPB, PatelRK, StevensKK, PalmerN: Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol18: 174, 2017PubMed
BakerRJ, MarkPB, PatelRK, StevensKK, PalmerN: Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol 18: 174, 2017PubMed)| false
KasiskeBL, ZeierMG, ChapmanJR, CraigJC, EkbergH, GarveyCA, et al; Kidney Disease: Improving Global Outcomes: KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int77: 299–311, 2010PubMed
KasiskeBL, ZeierMG, ChapmanJR, CraigJC, EkbergH, GarveyCA, et al; Kidney Disease: Improving Global Outcomes: KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int 77: 299–311, 2010PubMed)| false
YousifMEA, BridsonJM, HalawaA: Contraception after kidney transplantation, from myth to reality: A comprehensive review of the current evidence. Exp Clin Transplant14: 252–258, 2016PubMed
YousifMEA, BridsonJM, HalawaA: Contraception after kidney transplantation, from myth to reality: A comprehensive review of the current evidence. Exp Clin Transplant 14: 252–258, 2016PubMed)| false
AttiniR, CabidduG, MontersinoB, GammaroL, GernoneG, MoroniG, et al.Contraception in chronic kidney disease: A best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology. J Nephrol33: 1343–1359, 2020PubMed
AttiniR, CabidduG, MontersinoB, GammaroL, GernoneG, MoroniG, et al.Contraception in chronic kidney disease: A best practice position statement by the Kidney and Pregnancy Group of the Italian Society of Nephrology. J Nephrol 33: 1343–1359, 2020PubMed)| false
CollaL, DienaD, RossettiM, ManzioneAM, MarozioL, BenedettoC, et al.Immunosuppression in pregnant women with renal disease: Review of the latest evidence in the biologics era. J Nephrol31: 361–383, 2018PubMed
CollaL, DienaD, RossettiM, ManzioneAM, MarozioL, BenedettoC, et al.Immunosuppression in pregnant women with renal disease: Review of the latest evidence in the biologics era. J Nephrol 31: 361–383, 2018PubMed)| false
BoulayH, Mazaud-GuittotS, SupervielleJ, ChemounyJM, DardierV, LacroixA, et al.Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: A review. Clin Kidney J14: 1871–1878, 2021PubMed
BoulayH, Mazaud-GuittotS, SupervielleJ, ChemounyJM, DardierV, LacroixA, et al.Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: A review. Clin Kidney J 14: 1871–1878, 2021PubMed)| false
ZhengS, EasterlingTR, UmansJG, MiodovnikM, CalamiaJC, ThummelKE, et al.Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit34: 660–670, 2012PubMed
ZhengS, EasterlingTR, UmansJG, MiodovnikM, CalamiaJC, ThummelKE, et al.Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit 34: 660–670, 2012PubMed)| false
BramhamK, Nelson-PiercyC, GaoH, PierceM, BushN, SparkP, et al.Pregnancy in renal transplant recipients: A UK national cohort study. Clin J Am Soc Nephrol8: 290–298, 2013PubMed
BramhamK, Nelson-PiercyC, GaoH, PierceM, BushN, SparkP, et al.Pregnancy in renal transplant recipients: A UK national cohort study. Clin J Am Soc Nephrol 8: 290–298, 2013PubMed)| false
OkiR, UnagamiK, KakogawaJ, BeppuH, BannoT, YagisawaT, et al.Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. Transpl Int36: 11220, 2023PubMed
OkiR, UnagamiK, KakogawaJ, BeppuH, BannoT, YagisawaT, et al.Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. Transpl Int 36: 11220, 2023PubMed)| false
ShahS, VenkatesanRL, GuptaA, SanghaviMK, WelgeJ, JohansenR, et al.Pregnancy outcomes in women with kidney transplant: Metaanalysis and systematic review. BMC Nephrol20: 24, 2019PubMed
ShahS, VenkatesanRL, GuptaA, SanghaviMK, WelgeJ, JohansenR, et al.Pregnancy outcomes in women with kidney transplant: Metaanalysis and systematic review. BMC Nephrol 20: 24, 2019PubMed)| false
DeshpandeNA, JamesNT, KucirkaLM, BoyarskyBJ, Garonzik-WangJM, MontgomeryRA, et al.Pregnancy outcomes in kidney transplant recipients: A systematic review and meta-analysis. Am J Transplant11: 2388–2404, 2011PubMed
DeshpandeNA, JamesNT, KucirkaLM, BoyarskyBJ, Garonzik-WangJM, MontgomeryRA, et al.Pregnancy outcomes in kidney transplant recipients: A systematic review and meta-analysis. Am J Transplant 11: 2388–2404, 2011PubMed)| false
GosselinkME, van BurenMC, KooimanJ, GroenH, GanzevoortW, van HamersveltHW, et al.A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes. Kidney Int102: 866–875, 2022PubMed
GosselinkME, van BurenMC, KooimanJ, GroenH, GanzevoortW, van HamersveltHW, et al.A nationwide Dutch cohort study shows relatively good pregnancy outcomes after kidney transplantation and finds risk factors for adverse outcomes. Kidney Int 102: 866–875, 2022PubMed)| false
LentineKL, KasiskeBL, LeveyAS, AdamsPL, AlberúJ, BakrMA, et al.KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation101[Suppl 1]: S7–S105, 2017
LentineKL, KasiskeBL, LeveyAS, AdamsPL, AlberúJ, BakrMA, et al.KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation 101[Suppl 1]: S7–S105, 2017)| false
BellosI, PergialiotisV: Risk of pregnancy complications in living kidney donors: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol270: 35–41, 2022PubMed
BellosI, PergialiotisV: Risk of pregnancy complications in living kidney donors: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 270: 35–41, 2022PubMed)| false
DavisS, DylewskiJ, ShahPB, HolmenJ, YouZ, ChoncholM, et al.Risk of adverse maternal and fetal outcomes during pregnancy in living kidney donors: A matched cohort study. Clin Transplant33: e13453, 2019PubMed
DavisS, DylewskiJ, ShahPB, HolmenJ, YouZ, ChoncholM, et al.Risk of adverse maternal and fetal outcomes during pregnancy in living kidney donors: A matched cohort study. Clin Transplant 33: e13453, 2019PubMed)| false
O’KeeffeLM, RamondA, Oliver-WilliamsC, WilleitP, PaigeE, TrotterP, et al.Mid- and long-term health risks in living kidney donors: A systematic review and meta-analysis. Ann Intern Med168: 276–284, 2018PubMed
O’KeeffeLM, RamondA, Oliver-WilliamsC, WilleitP, PaigeE, TrotterP, et al.Mid- and long-term health risks in living kidney donors: A systematic review and meta-analysis. Ann Intern Med 168: 276–284, 2018PubMed)| false